|Bid||134.50 x 1000|
|Ask||135.70 x 1000|
|Day's Range||133.03 - 137.39|
|52 Week Range||100.32 - 140.62|
|Beta (3Y Monthly)||0.46|
|PE Ratio (TTM)||26.54|
|Earnings Date||Oct 22, 2019|
|Forward Dividend & Yield||4.12 (3.07%)|
|1y Target Est||130.00|
Kimberly-Clark's (KMB) second-quarter performance marked robust organic sales growth, improved gross margin, cost savings efforts and increase investments in brands.
On July 23, Kimberly-Clark (KMB) posted stronger-than-expected second-quarter earnings results. It surpassed analysts’ expectations on both the sales and EPS fronts.
AB InBev (BUD) is poised for growth in second-quarter 2019, owing to strong sales trend and persistent strength in global brands. However, weakness in some markets and soft beer volume may affect results.
Consumer products giant Kimberly Clark started to reap the rewards of a price hike gamble, beating expectations in the second quarter.
Kimberly-Clark (KMB) delivered earnings and revenue surprises of 1.83% and -0.22%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Kimberly-Clark Corp. shares rose 2.4% in Tuesday premarket trading after the Kleenex company reported second-quarter earnings that beat expectations and raised its full-year guidance. Net income totaled $485.0 million, or $1.40, up from $455.0 million, or $1.30 per share, last year. Adjusted EPS was $1.67, beating the $1.61 per share FactSet consensus. Sales of $4.59 billion was down slightly from $4.60 billion last year but just ahead of the $4.58 billion FactSet expectation. Kimberly-Clark now expects full-year adjusted earnings to be $6.65 to $6.80, up from previous guidance of $6.50 to $6.70. The FactSet consensus is for $6.76. Net sales are now expected to be even-to-down 1% year-over-year versus prior guidance for a 1%-to-2% decline. Kimberly-Clark stock is up nearly 18% for the year to date while the S&P 500 index is up 19.1% for the period.
DALLAS , July 23, 2019 /PRNewswire/ -- Kimberly-Clark Corporation (NYSE: KMB) today reported second quarter 2019 results and raised its outlook for full-year 2019 organic sales growth and earnings per ...
Kimberly-Clark (KMB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
FEMSA's (FMX) second-quarter 2019 results are likely to be impacted by ongoing cost headwinds, which should continue to hurt margins. However, its growth efforts might provide some respite.
Philip Morris' (PM) Q2 results gain from growth in heated tobacco units and favorable pricing. However, decline in cigarette shipment volumes were a drag.
Kimberly-Clark (KMB) will likely report its second-quarter results before the markets open on July 23. We expect the company's sales and earnings to stay muted.
Nu Skin's (NUS) Q2 and 2019 results are likely to be hurt by weak performance in China, triggered by government's product review initiatives.
Boston Beer (SAM) is likely to deliver robust second-quarter 2019 results on continued depletion and shipment growth. However, rising costs and a sluggish Samuel Adams brand may act spoilsport.
Kimberly-Clark (KMB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Coca-Cola's (KO) strategy of introducing new products with focus on expanding successful brands globally is aiding its performance. However, adverse currency may mar second-quarter 2019 results.